Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder
Journal
Journal of Child and Adolescent Psychopharmacology
Journal Volume
31
Journal Issue
3
Pages
187-196
Date Issued
2021
Author(s)
Abstract
Both OROS-MPH and atomoxetine improved various domains of executive functions in children with ADHD. There is greater improvement in response selection/inhibition among patients treated with OROS-MPH than those with atomoxetine. This trial was registered with ClinicalTrials.gov (no. NCT00916786).
SDGs
Type
journal article